FCGRIIIA and IGHG (GM) Genotypes and Immunity to HSV1 in Herpes Stromal Keratitis
FCGRIIIA and IGHG (GM) Genotypes and Immunity to HSV1 in Herpes Stromal Keratitis
批准号:
10675575
负责人:
JANARDAN P PANDEY
金额:
$18.88万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-01 至 2024-08-31
关键词:
AffinityAffinity ChromatographyAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAntibodiesAntibody ResponseAntibody TherapyAntigensBindingBlindnessCandidate Disease GeneCellsChromosome 14ChromosomesComplexDNADevelopmentDiseaseDisease ProgressionDisparateEffector CellEpithelial CellsFc domainGene ModifiedGenesGeneticGenetic VariationGenomeGenomicsGenotypeGlycoproteinsHerpes stromal keratitisHerpesviridaeHerpesvirus 1HumanHumoral ImmunitiesIGH@ gene clusterIgG1ImmuneImmune systemImmunityImmunobiologyImmunoglobulin GImmunoglobulin GenesImmunoglobulinsImmunologicsImmunotherapyIncidenceIndividualInfectionInvestigationLigationLinkLinkage DisequilibriumMediatingMusNatural Killer CellsOutcomePathogenesisPatientsPatternPersonsPredispositionPrevalenceProteinsReceptor GeneRiskRisk FactorsRoleSimplexvirusSusceptibility GeneTestingTherapeutic Monoclonal AntibodiesTransfectionUnited StatesVariantViralVirusantibody-dependent cell cytotoxicitycorneal epitheliumdesigngenome wide association studygenotyping technologyimprovedmannovelreceptorresponserisk variantvaccine candidatevirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Herpes stromal keratitis (HSK), induced by herpes simplex virus type 1 (HSV1), is the most common cause of
infectious blindness in the United States. HSV1 is a common virus and not all HSV1-infected people are
equally likely to develop HSK, suggesting the involvement of host genetic factors in the development of this
disorder. Immunoglobulin GM (g marker) allotypes, encoded by IGHG1, IGHG2, and IGHG3 genes on
chromosome 14, are excellent candidate genes for involvement in HSK etiopathogenesis because they
modulate HSV1 immunoevasion strategies. The HSV1-encoded decoy Fcg receptor (FcgR), the gE-gl
glycoprotein complex, which the virus uses to thwart host’s Fc-mediated effector functions, such as antibody-
dependent cellular cytotoxicity (ADCC), binds differentially to IgG antibodies expressing different GM allotypes.
IgG1 proteins expressing GM 1,17 alleles have strikingly higher affinity for the viral decoy FcgR than those
expressing the alternative GM 1-,3 alleles. In addition, GM genes, epistatically with cellular FcgR genes,
contribute to the magnitude of ADCC of HSV1-infected cells. Based on these observations, we hypothesize
that GM and FcgRIIIa genes are risk factors for HSK, and the underlying mechanisms include their contribution
to the humoral immunity to HSV1 proteins and to the ADCC of HSV1-infected corneal epithelial cells. The
following specific aims will test our hypothesis: Aim1: Determine if GM and FcgRIIIa genotypes are risk factors
for HSK. DNA from HSK patients and controls will be characterized for several GM and FcgRIIIa alleles to
assess whether these genes—individually or epistatically—are risk factors for HSK; Aim 2: Determine if the
magnitude of antibody responsiveness to particular HSV1 proteins is associated with GM and FcgRIIIa alleles.
We will quantitate antibody responses to HSV1-gD (a major glycoprotein and vaccine candidate) in the sera of
HSK patients and controls and determine if the magnitude of antibody responsiveness is associated with GM
and FcgRIIIa genotypes; Aim 3: Determine if particular allelic combinations of Fc (GM) and cellular FcgR alleles
influence the level of ADCC. IgG antibody mediated ADCC is triggered upon ligation of FcγR (expressed on
effector cells) to the Fc region of anti-viral IgG antibodies. It follows that genetic variation in FcγR and Fc,
where virtually all GM alleles are expressed, could contribute to the differences in the magnitude of ADCC.
Using HSV-gD-transfected corneal epithelial cells as target, affinity purified, allotypically disparate anti-HSV1-
gD antibodies from HSK patients, and NK cells (expressing different FcgRIIIa alleles) as effectors, we will
determine whether the level of ADCC is associated with particular combinations of Fcg (GM) and FcgRIIIa
alleles. The results of this investigation will enhance our understanding of the genetics of Fc-mediated effector
mechanisms underlying the HSV1-HSK association. This will inform improvements in the design of viral
immunogens that may generate protective antibody Fc effector responses as well as in the design of the Fc
region of therapeutic monoclonal antibodies for the treatment of this disorder.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunoglobulin Genes and Immunity to HSV1 in Alzheimer's Disease
-
批准号:10576613
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2023
-
负责人:JANARDAN P PANDEY
-
依托单位:
IGHG Genes (GM Allotypes) and Anti-CMV (UL70) Antibody Responses as Prognostic Markers for Chronic Graft-Versus-Host-Disease
-
批准号:10624498
-
项目类别:
-
资助金额:$11.33万
-
财政年份:2023
-
负责人:JANARDAN P PANDEY
-
依托单位:
FCGRIIIA and IGHG (GM) Genotypes and Immunity to HSV1 in Herpes Stromal Keratitis
-
批准号:10507311
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2022
-
负责人:JANARDAN P PANDEY
-
依托单位:
Immunoglobulin GM (γ marker) Allotypes and Immunity to HSV1 in Alzheimer’s Disease
-
批准号:10464940
-
项目类别:
-
资助金额:$36.7万
-
财政年份:2021
-
负责人:JANARDAN P PANDEY
-
依托单位:
Genetic Markers of IgG and Cytomegalovirus Immunoevasion in Alzheimer Disease
-
批准号:9386264
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2017
-
负责人:JANARDAN P PANDEY
-
依托单位:
Genetic Modifiers of Immune Evasion by Cytomegalovirus in Glioblastoma
-
批准号:8465930
-
项目类别:
-
资助金额:$17.79万
-
财政年份:2012
-
负责人:JANARDAN P PANDEY
-
依托单位:
Genetic Modifiers of Immune Evasion by Cytomegalovirus in Glioblastoma
-
批准号:8374071
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2012
-
负责人:JANARDAN P PANDEY
-
依托单位:
Immunoglobulin Allotypes in Hepatitis C Virus Infection
-
批准号:7029163
-
项目类别:
-
资助金额:$19.6万
-
财政年份:2006
-
负责人:JANARDAN P PANDEY
-
依托单位:
Immunoglobulin Allotypes in Hepatitis C Virus Infection
-
批准号:7367031
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2006
-
负责人:JANARDAN P PANDEY
-
依托单位:
Immunoglobulin Allotypes in Hepatitis C Virus Infection
-
批准号:7188051
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2006
-
负责人:JANARDAN P PANDEY
-
依托单位:
TUMOR NECROSIS FACTOR ALPHA AND KM POLYMORPHISMS IN GRAVES DISEASE
-
批准号:6119067
-
项目类别:
-
资助金额:$1.74万
-
财政年份:1998
-
负责人:JANARDAN P PANDEY
-
依托单位:
TUMOR NECROSIS FACTOR ALPHA AND KM POLYMORPHISMS IN GRAVES DISEASE
-
批准号:6280088
-
项目类别:
-
资助金额:$2.73万
-
财政年份:1997
-
负责人:JANARDAN P PANDEY
-
依托单位:
TUMOR NECROSIS FACTOR ALPHA AND KM POLYMORPHISMS IN GRAVES DISEASE
-
批准号:6250299
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1997
-
负责人:JANARDAN P PANDEY
-
依托单位:
IMMUNOGLOBULIN ALLOTYPE LINKED IMMUNE RESPONSE GENES
-
批准号:3868793
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JANARDAN P PANDEY
-
依托单位:
DNA AND GM POLYMORPHISMS IN FAMILIAL POLYPOSIS COLI
-
批准号:3955627
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JANARDAN P PANDEY
-
依托单位:
DNA & GM POLYMORPHISMS IN FAMILIAL POLYPOSIS COLI: GENETICS, CANCER, MARKER
-
批准号:3932913
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JANARDAN P PANDEY
-
依托单位:
海外基金